Literature DB >> 16214644

Pain management of sickle cell disease.

Samir K Ballas1.   

Abstract

Management of sickle cell disease continues to be primarily palliative, including supportive, symptomatic, and preventive approaches to therapy. There are three major types of sickle cell pain: acute, chronic, and neuropathic pain. The acute painful episode is the insignia of the disease and the most common cause of hospitalization. Its management entails the use of nonpharmacologic and pharmacologic modalities. Pain management should follow certain principles that include an assessment stage, treatment stage, reassessment stage, and adjustment stage. Chronic sickle cell pain may be due to certain complications of the disease, such as leg ulcers and avascular necrosis; intractable chronic pain may be due to central sensitization. Management of chronic pain should take a multidisciplinary approach.

Entities:  

Mesh:

Year:  2005        PMID: 16214644     DOI: 10.1016/j.hoc.2005.07.008

Source DB:  PubMed          Journal:  Hematol Oncol Clin North Am        ISSN: 0889-8588            Impact factor:   3.722


  47 in total

1.  Applicability of the SMART Model of Transition Readiness for Sickle-Cell Disease.

Authors:  Siddika S Mulchan; Jessica M Valenzuela; Lori E Crosby; Claudia Diaz Pow Sang
Journal:  J Pediatr Psychol       Date:  2015-12-30

2.  CE: Understanding the Complications of Sickle Cell Disease.

Authors:  Paula Tanabe; Regena Spratling; Dana Smith; Peyton Grissom; Mary Hulihan
Journal:  Am J Nurs       Date:  2019-06       Impact factor: 2.220

3.  Evaluation and Treatment of Sickle Cell Pain in the Emergency Department: Paths to a Better Future.

Authors:  William T Zempsky
Journal:  Clin Pediatr Emerg Med       Date:  2010-12-01

4.  Pain site frequency and location in sickle cell disease: the PiSCES project.

Authors:  Donna K McClish; Wally R Smith; Bassam A Dahman; James L Levenson; John D Roberts; Lynne T Penberthy; Imoigele P Aisiku; Susan D Roseff; Viktor E Bovbjerg
Journal:  Pain       Date:  2009-07-23       Impact factor: 6.961

5.  Successful Aging with Sickle Cell Disease: Using Qualitative Methods to Inform Theory.

Authors:  Coretta M Jenerette; Gloria Lauderdale
Journal:  J Theory Constr Test       Date:  2008-04-01

6.  Individuals with sickle cell disease have a significantly greater vasoconstriction response to thermal pain than controls and have significant vasoconstriction in response to anticipation of pain.

Authors:  Maha Khaleel; Mammen Puliyel; Payal Shah; John Sunwoo; Roberta M Kato; Patjanaporn Chalacheva; Wanwara Thuptimdang; Jon Detterich; John C Wood; Jennie Tsao; Lonnie Zeltzer; Richard Sposto; Michael C K Khoo; Thomas D Coates
Journal:  Am J Hematol       Date:  2017-08-17       Impact factor: 10.047

Review 7.  Fluid replacement therapy for acute episodes of pain in people with sickle cell disease.

Authors:  Uduak Okomo; Martin M Meremikwu
Journal:  Cochrane Database Syst Rev       Date:  2017-07-31

8.  Chronic transfusion therapy improves but does not normalize systemic and pulmonary vasculopathy in sickle cell disease.

Authors:  Jon A Detterich; Roberta M Kato; Miklos Rabai; Herbert J Meiselman; Thomas D Coates; John C Wood
Journal:  Blood       Date:  2015-06-02       Impact factor: 22.113

9.  USING LIVED EXPERIENCES OF ADULTS TO UNDERSTAND CHRONIC PAIN: SICKLE CELL DISEASE, AN EXEMPLAR.

Authors:  Maxine A Adegbola
Journal:  Imanagers J Nurs       Date:  2011

Review 10.  The analgesic potential of cannabinoids.

Authors:  Jaseena Elikkottil; Jaseena Elikottil; Pankaj Gupta; Kalpna Gupta
Journal:  J Opioid Manag       Date:  2009 Nov-Dec
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.